Clinical Overview of Depression & Related Mood Disorders

A Comprehensive Guide to Classification, Pathophysiology, Diagnostics, and Therapeutics

1. Introduction & Global Burden

Depressive disorders represent a broad category of psychiatric conditions characterized by persistent sadness, anhedonia (the loss of interest or pleasure in daily activities), feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration. According to the World Health Organization (WHO), depression affects over 280 million people globally and stands as a leading cause of disability worldwide, significantly contributing to the overall global burden of disease.

Diagnostic Distinction

Depression is distinct from transient emotional fluctuations and daily grief. A clinical diagnosis requires persistent symptoms lasting at least two weeks that cause marked distress and functional impairment across personal, social, and occupational domains.

2. Spectrum of Depressive & Related Disorders

The Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) classifies depressive disorders into several discrete diagnostic entities, each with unique clinical presentations and disease courses:

Disorder	Core Diagnostic Criteria	Clinical Features & Duration
Major Depressive Disorder (MDD)	≥ 5 symptoms present for ≥ 2 weeks, including depressed mood or anhedonia.	Episodic nature; severe distress; high risk of cognitive impairment and somatic symptoms.
Persistent Depressive Disorder (Dysthymia)	Depressed mood for most of the day, for more days than not, for ≥ 2 years.	Chronic low-grade depression; insidious onset; high rate of comorbid anxiety.
Premenstrual Dysphoric Disorder (PMDD)	Severe mood instability, irritability, and anxiety during the luteal phase of the menstrual cycle.	Symptoms remit shortly after onset of menses; causes severe functional impairment.
Disruptive Mood Dysregulation Disorder	Severe recurrent temper outbursts grossly out of proportion to the situation in children (ages 6–18).	Persistent irritable or angry mood between outbursts; developed to prevent over-diagnosis of pediatric bipolar disorder.
Substance/Medication-Induced Depressive Disorder	Persistent depressive symptoms directly attributable to substance abuse, toxin exposure, or prescription drugs.	Resolves upon withdrawal or discontinuation of offending pharmacological agent.

3. Evidence-Based Treatment Framework

Psychotherapeutic Modalities

First-line psychotherapy includes Cognitive Behavioral Therapy (CBT), Interpersonal Therapy (IPT), and Acceptance and Commitment Therapy (ACT). CBT focuses on cognitive restructuring to address maladaptive thought patterns and behavioral activation to increase engagement in rewarding activities.